Format

Send to

Choose Destination
Rheumatol Int. 2006 Jun;26(8):752-7. Epub 2005 Oct 25.

Health-related quality of life in rheumatoid arthritis: therapeutic education plus pharmacological treatment versus pharmacological treatment only.

Author information

1
Rheumatology Department, Musculoskeletal Clínic Institute (ICAL), Hospital Clínic, Villarroel 170, 08036, Barcelona, Spain. mnunez@clinic.ub.es

Abstract

OBJECTIVE:

To determine whether therapeutic education added to conventional drug therapy reduced disability and pain in patients with early rheumatoid arthritis (RA).

METHODS:

Fourty-three patients with RA, 29F/14 M, were included in a randomized, controlled trial and assigned to a control group receiving conventional pharmacological treatment only (n=21), or an intervention group receiving therapeutic education added to conventional pharmacological treatment (n=22). The main outcome variable was self-reported disability on the Stanford health assessment questionnaire (HAQ).

RESULTS:

At 18 months, patients in the intervention group had less disability (HAQ), pain intensity, number of tender and swollen joints, and patient's and physician's global assessments (p=0.003, 0.031, 0.003, 0.001, 0.014, and 0.004, respectively) compared with baseline, and improvements in disability and number of tender and swollen joints (p=0.024, 0.040, and 0.003, respectively), compared with controls.

CONCLUSIONS:

Patients receiving pharmacological treatment and therapeutic education had a better evolution than those receiving only pharmacological treatment.

PMID:
16247548
DOI:
10.1007/s00296-005-0071-6
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center